Clinical Trial Update: Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer Pain (FT-015-IN) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing FITpatch with standard opioid therapy for cancer-related chronic pain has completed, evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Pain

Drugs mentioned

• FITpatch

Snippet

Sponsor: Nycomed | Conditions: Standard Opioid Analgesic Treatment of Cancer-related Chronic Pain. | Phase 3 | Status: COMPLETED